Caresyntax, a leading vendor-neutral precision surgery platform, has announced a significant funding round of $180 million. The financing, which includes a Series C extension and growth debt expansion, comprises $80 million in equity and up to $100 million in growth debt facility.
https://twitter.com/caresyntax/status/1824053647111786942?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet
The funding round attracted a diverse group of investors, including Symbiotic Capital, MTIP AG, BIONIQ Capital, PFM Health Sciences, Pictet Alternative Advisors, surgical.ai, BlackRock Innovation Capital, and several others.
Caresyntax's platform aims to transform surgery by implementing a scalable, end-to-end software and AI solution. The medical-grade, interoperable platform captures novel
AI Health Startup Caresyntax Raises $180M to Bring AI Smarts to the Operating Room
- By Abhijeet Adhikari
- Published on
The funding round attracted a diverse group of investors, including Symbiotic Capital, MTIP AG, BIONIQ Capital, PFM Health Sciences, Pictet Alternative Advisors, surgical.ai, BlackRock Innovation Capital, and several others.
